Proposed Data Collections Submitted for Public Comment and Recommendations, 33302-33303 [2011-14145]

Download as PDF 33302 Federal Register / Vol. 76, No. 110 / Wednesday, June 8, 2011 / Notices No. 0920–0591 exp. 2/28/2011)— Reinstatement without change— National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention (CDC), officially established as a substructure on July 9, 2010. DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30Day–11–0591] Agency Forms Undergoing Paperwork Reduction Act Review Background and Brief Description The Centers for Disease Control and Prevention (CDC) publishes a list of information collection requests under review by the Office of Management and Budget (OMB) in compliance with the Paperwork Reduction Act (44 U.S.C. chapter 35). To request a copy of these requests, call the CDC Reports Clearance Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of Management and Budget, Washington, DC or by fax to (202) 395–5806. Written comments should be received within 30 days of this notice. The Centers for Disease Control and Prevention is requesting a three year extension to continue data collection under the Select Agent Distribution Activity. The form used for this activity is currently approved under OMB Control No. 0920–0591. The purpose of this data collection is to provide a systematic and consistent mechanism to review requests that come to CDC for Select Agents. The term select agents is used to described a limited group of viruses, bacteria, rickettsia, and toxins that have the potential for use as agents of bioterrorism, inflicting significant morbidity and mortality on susceptible populations. In light of current terrorism concerns and the significant NIH grant monies Proposed Project Select Agent Distribution Activity: Request for Select Agent (OMB Control directed toward Select Agent research, CDC receives hundreds of requests for Select Agents from researchers. The approximately 900 applicants are required to complete an application form in which they identify themselves and their institution, provide a Curriculum Vitae or biographical sketch, a summary of their research proposal, and sign indemnification and material transfer agreement statements. In this request, CDC is requesting approval for approximately 450 hours; no change from the currently approved burden. The only correction to this data collection request is updating the name of the National Center on the application form. A user fee will be collected to recover costs for materials, handling and shipping (except for public health laboratories). The cost to the respondent will vary based on which agent is requested. Estimate of Annualized Burden Hours Respondent Number of respondents Number of responses per respondent Average burden per response (in hours) Researcher .................................................................................................................................. 900 1 30/60 Dated: May 31, 2011. Daniel Holcomb, Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. 2011–14143 Filed 6–7–11; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60Day-11–11HD] sroberts on DSK5SPTVN1PROD with NOTICES Proposed Data Collections Submitted for Public Comment and Recommendations In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 for opportunity for public comment on proposed data collection projects, the Centers for Disease Control and Prevention (CDC) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the data collection plans and instruments, call 404–639–5960 or send comments to Daniel Holcomb, CDC VerDate Mar<15>2010 21:51 Jun 07, 2011 Jkt 223001 Acting Reports Clearance Officer, 1600 Clifton Road, MS D–74, Atlanta, GA 30333 or send an e-mail to omb@cdc.gov. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Written comments should be received within 60 days of this notice. Proposed Project Study of Comprehensive Cancer Control and Tobacco Control Program Partnerships — New — Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention (CDC). PO 00000 Frm 00112 Fmt 4703 Sfmt 4703 Background and Brief Description Tobacco use remains the leading preventable cause of death in the United States, causing over 443,000 deaths each year and resulting in an annual cost of more than $96 billion in direct medical expenses. According to the latest Report of the Surgeon General (2010), ‘‘How Tobacco Causes Disease,’’ damage from tobacco smoke is immediate. Inhaling the over 7,000 chemicals and compounds in tobacco smoke causes immediate and long-term damage and leads to disease, including cancer, and death. The only proven strategy for reducing the risk of tobacco-related morbidity and mortality is to never smoke, or to quit if tobacco use has been initiated. In 1999, CDC’s Office on Smoking and Health (OSH) established the National Tobacco Control Program (NTCP) to encourage coordinated, national efforts to reduce tobacco-related morbidity and mortality. The NTCP provides funding and technical support to Tobacco Control Programs (TCPs) in all 50 states, the District of Columbia, seven tribal support centers, eight U.S. territories or jurisdictions, and six national networks. NTCP awardees implement evidence- E:\FR\FM\08JNN1.SGM 08JNN1 33303 Federal Register / Vol. 76, No. 110 / Wednesday, June 8, 2011 / Notices based tobacco control policies and interventions including telephone quitlines to increase tobacco use cessation. Tobacco control is also a top priority for federally-funded cancer control programs. Currently, 65 organizations are funded through CDC’s National Comprehensive Cancer Control Program (NCCCP): all 50 states, the District of Columbia, seven tribes/tribal organizations, and seven U.S. territories/Pacific Island Jurisdictions. NCCCP grantees are charged with establishing NCCCP coalitions, assessing the burden of cancer, and developing and implementing comprehensive cancer control (CCC) plans. The CCC plans address interventions across the cancer continuum from primary prevention to treatment and survivorship. The NCCCP is managed by CDC’s Division of Cancer Prevention and Control (DCPC). CDC recognizes the need for increased collaboration between CCCs and TCPs. Toward this end, CDC plans to conduct a study of current partnership efforts involving NCCCP awardees and NTCP awardees. Information will be collected to improve understanding of the ways in which CCCs and TCPs may collaborate to address cancer and tobacco control, and how these programs utilize their respective networks to cross-promote activities. The Partnership Study will be conducted in seven states that: (1) Are funded through both the NCCCP and the NTCP and (2) have an established relationship between the two programs. Respondents for the Study of Comprehensive Cancer Control and Tobacco Control Program Partnerships will be state health department leaders, CCC and TCP staff (e.g., program directors, evaluation specialists, media specialists, quitline coordinators), and other stakeholders, such as coalition members. Information will be collected through in-person interviews involving approximately 15 respondents in each state. Respondents will be asked about key aspects of their program’s structure and activities, including efforts to coordinate across the CCC–TCP structure and facilitators and/or barriers influencing CCC–TCP collaborations. The questions in each interview will be customized depending on the respondent’s role. Each interview will last approximately 45 minutes to one hour. CDC plans to request OMB approval for one year. The information to be collected in the Partnership Study will be used to develop examples of successful strategies used by selected CCCs and TCPs to cross-collaborate and cross-promote programs/services, and to identify new areas of potential collaboration that may be shared with CDC, other federal agencies, and other CCC and TCP states for replication. The Partnership Study will complement and extend the usefulness of results to be obtained in a companion study titled ‘‘Comparing the Effectiveness of Traditional EvidenceBased Tobacco Cessation Interventions to Newer and Innovative Interventions Used by Comprehensive Cancer Control Programs.’’ Additional information about the companion project will be published in a separate Federal Register Notice. Both studies will be funded through the American Recovery and Reinvestment Act of 2009 (ARRA). There are no costs to respondents other than their time. ESTIMATED ANNUALIZED BURDEN HOURS Form name State Health Department Leadership Interview Guide for Health Department Leadership. Site Visit Preparation ....................... 49 ..................................................... Site Visit Preparation ....................... 49 ..................................................... ........................................................... CCC Programs .................................. Interview Guide for CCCs ................. Tobacco Control Programs ............... Interview Guide for TCPs ................. Total ........................................... Dated: June 1, 2011. Daniel Holcomb, Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. 2011–14145 Filed 6–7–11; 8:45 am] BILLING CODE;P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention sroberts on DSK5SPTVN1PROD with NOTICES [60Day-11–11GU] Proposed Data Collections Submitted for Public Comment and Recommendations In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 for opportunity for public comment on VerDate Mar<15>2010 21:51 Jun 07, 2011 Jkt 223001 Frm 00113 Fmt 4703 Total burden (in hours) 7 1 45/60 5 7 1 7 1 ........................ 1 1 1 1 ........................ 45/60 49 45/60 49 113 5 proposed data collection projects, the Centers for Disease Control and Prevention (CDC) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the data collection plans and instruments, call 404–639–5960 and send comments to Daniel Holcomb, CDC Reports Clearance Officer, 1600 Clifton Road, MS–D74, Atlanta, GA 30333 or send an e-mail to omb@cdc.gov. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the PO 00000 Average burden per response (in hours) No. of responses per respondent Total number of respondents Type of respondent Sfmt 4703 burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Written comments should be received within 60 days of this notice. Proposed Project Survey of Rapid Influenza Diagnostic Test (RIDT) Practices in Clinical Laboratories—New—the Office of Surveillance, Epidemiology, and Laboratory Services (OSELS), Centers for Disease Control and Prevention (CDC). Background and Brief Description The Survey of Rapid Influenza Diagnostic Testing Practices in Clinical Laboratories is a national systematic study investigating rapid influenza diagnostic testing practices in clinical E:\FR\FM\08JNN1.SGM 08JNN1 5

Agencies

[Federal Register Volume 76, Number 110 (Wednesday, June 8, 2011)]
[Notices]
[Pages 33302-33303]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-14145]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-11-11HD]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of Section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call 404-639-5960 or 
send comments to Daniel Holcomb, CDC Acting Reports Clearance Officer, 
1600 Clifton Road, MS D-74, Atlanta, GA 30333 or send an e-mail to 
omb@cdc.gov.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology. Written comments should be received 
within 60 days of this notice.

Proposed Project

    Study of Comprehensive Cancer Control and Tobacco Control Program 
Partnerships -- New -- Division of Cancer Prevention and Control, 
National Center for Chronic Disease Prevention and Health Promotion, 
Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    Tobacco use remains the leading preventable cause of death in the 
United States, causing over 443,000 deaths each year and resulting in 
an annual cost of more than $96 billion in direct medical expenses. 
According to the latest Report of the Surgeon General (2010), ``How 
Tobacco Causes Disease,'' damage from tobacco smoke is immediate. 
Inhaling the over 7,000 chemicals and compounds in tobacco smoke causes 
immediate and long-term damage and leads to disease, including cancer, 
and death. The only proven strategy for reducing the risk of tobacco-
related morbidity and mortality is to never smoke, or to quit if 
tobacco use has been initiated.
    In 1999, CDC's Office on Smoking and Health (OSH) established the 
National Tobacco Control Program (NTCP) to encourage coordinated, 
national efforts to reduce tobacco-related morbidity and mortality. The 
NTCP provides funding and technical support to Tobacco Control Programs 
(TCPs) in all 50 states, the District of Columbia, seven tribal support 
centers, eight U.S. territories or jurisdictions, and six national 
networks. NTCP awardees implement evidence-

[[Page 33303]]

based tobacco control policies and interventions including telephone 
quitlines to increase tobacco use cessation.
    Tobacco control is also a top priority for federally-funded cancer 
control programs. Currently, 65 organizations are funded through CDC's 
National Comprehensive Cancer Control Program (NCCCP): all 50 states, 
the District of Columbia, seven tribes/tribal organizations, and seven 
U.S. territories/Pacific Island Jurisdictions. NCCCP grantees are 
charged with establishing NCCCP coalitions, assessing the burden of 
cancer, and developing and implementing comprehensive cancer control 
(CCC) plans. The CCC plans address interventions across the cancer 
continuum from primary prevention to treatment and survivorship. The 
NCCCP is managed by CDC's Division of Cancer Prevention and Control 
(DCPC).
    CDC recognizes the need for increased collaboration between CCCs 
and TCPs. Toward this end, CDC plans to conduct a study of current 
partnership efforts involving NCCCP awardees and NTCP awardees. 
Information will be collected to improve understanding of the ways in 
which CCCs and TCPs may collaborate to address cancer and tobacco 
control, and how these programs utilize their respective networks to 
cross-promote activities. The Partnership Study will be conducted in 
seven states that: (1) Are funded through both the NCCCP and the NTCP 
and (2) have an established relationship between the two programs.
    Respondents for the Study of Comprehensive Cancer Control and 
Tobacco Control Program Partnerships will be state health department 
leaders, CCC and TCP staff (e.g., program directors, evaluation 
specialists, media specialists, quitline coordinators), and other 
stakeholders, such as coalition members. Information will be collected 
through in-person interviews involving approximately 15 respondents in 
each state. Respondents will be asked about key aspects of their 
program's structure and activities, including efforts to coordinate 
across the CCC-TCP structure and facilitators and/or barriers 
influencing CCC-TCP collaborations. The questions in each interview 
will be customized depending on the respondent's role. Each interview 
will last approximately 45 minutes to one hour.
    CDC plans to request OMB approval for one year. The information to 
be collected in the Partnership Study will be used to develop examples 
of successful strategies used by selected CCCs and TCPs to cross-
collaborate and cross-promote programs/services, and to identify new 
areas of potential collaboration that may be shared with CDC, other 
federal agencies, and other CCC and TCP states for replication.
    The Partnership Study will complement and extend the usefulness of 
results to be obtained in a companion study titled ``Comparing the 
Effectiveness of Traditional Evidence-Based Tobacco Cessation 
Interventions to Newer and Innovative Interventions Used by 
Comprehensive Cancer Control Programs.'' Additional information about 
the companion project will be published in a separate Federal Register 
Notice. Both studies will be funded through the American Recovery and 
Reinvestment Act of 2009 (ARRA). There are no costs to respondents 
other than their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                      No. of      Average burden
      Type of respondent            Form name      Total number    responses per   per response    Total burden
                                                  of respondents    respondent      (in hours)      (in hours)
----------------------------------------------------------------------------------------------------------------
State Health Department         Interview Guide                7               1           45/60               5
 Leadership.                     for Health
                                 Department
                                 Leadership.
CCC Programs..................  Site Visit                     7               1           45/60               5
                                 Preparation.
Interview Guide for CCCs......  49..............               1               1              49
Tobacco Control Programs......  Site Visit                     7               1           45/60               5
                                 Preparation.
Interview Guide for TCPs......  49..............               1               1              49
    Total.....................  ................  ..............  ..............             113
----------------------------------------------------------------------------------------------------------------


    Dated: June 1, 2011.
Daniel Holcomb,
Reports Clearance Officer, Centers for Disease Control and Prevention.
[FR Doc. 2011-14145 Filed 6-7-11; 8:45 am]
BILLING CODE;P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.